Consultation on recommended changes of the reimbursement status of lipid-lowering medicinal products
At several meetings, the Reimbursement Committee has discussed the reimbursement status of lipid-lowering medicinal products. In its recommendation of 7 September 2006 for The Danish Medicines Agency, the Committee suggests a change of reimbursement status for these medicinal products. The Danish Medicines Agency has asked for potential comments on the recommendation from scientific societies, the National Board of Health as well as companies holding marketing authorisations for medicinal products included in the recommendation. You can find the letter and the Reimbursement Committee’s recommendation on the reimbursement status of lipid-lowering medicines in the fact box to the right. The deadline for submitting comments is 20 December 2006.
For further information, please contact the Reimbursement Department, email@example.com.
The Danish Medicines Agency, 25 September 2006